Connect with others who understand.

sign up log in
Resources
About MyMSTeam
Powered By

MS Drug Costs Skyrocket After Medicare Rule Change: Study

Posted on March 18, 2019
View reactions

WEDNESDAY, Feb. 6, 2019 (HealthDay News) -- Medicare rule changes could trigger a spike in out-of-pocket drug costs for patients with multiple sclerosis (MS).

Due to rules that restrict access and require patients to cover more of the cost, those without low-income subsidies can expect to spend almost $6,900 a year out of pocket for MS medicines, researchers reported.

"It's a dysfunctional market that lacks the typical incentives for most other consumer products," said lead author Daniel Hartung. "Aside from the public optics, there are few incentives for companies not to raise prices. Most intermediaries in the drug distribution channel, including drug companies, benefit from higher prices."

Hartung is an associate professor at the College of Pharmacy of Oregon Health and Science University (OHSU) and Oregon State University.

MS is an unpredictable disease of the central nervous system, resulting in symptoms that include vision problems, muscle weakness, tremors and difficulty with balance and coordination.

Out-of-pocket drug costs are often tied to undiscounted list prices, and there appears to be a link between rising prices for MS drugs and more use of restrictive policies by Medicare drug plans, according to the researchers.

For example, they found that patients who are prescribed the only generic drug in one class -- glatiramer acetate -- will pay more out of pocket than patients using any brand-name drugs in the same class.

Medicare rule changes last year were meant to reduce patients' out-of-pocket costs through increased discounts from brand-name drug manufacturers. But the change resulted in higher out-of-pocket costs for users of certain generic products.

"This is a pernicious effect of the release of a generic and an unfortunate effect of Medicare rules," study co-author Dr. Dennis Bourdette said in an OHSU news release. Bourdette is chairman of neurology at the OHSU School of Medicine in Portland.

A Trump administration proposal to address this incentive disparity between brand-name and generic drugs could reduce patients' total out-of-pocket spending, according to the researchers.

"Despite increases in the number and diversity of disease-modifying therapies for MS, prices have risen rapidly over the past two decades," Bourdette's team wrote. "The rise in high coinsurance cost-sharing models, coupled with escalating drug prices, means that patients will increasingly face prohibitive out-of-pocket spending."

The study appears in the February issue of the journal Health Affairs.
SOURCE: Oregon Health and Science University, news release, Feb. 4, 2019

Copyright © 2019 All rights reserved.

Have you ever NOT been able to afford your MS medications? Share in the comments below!

Posted on March 18, 2019
View reactions
All updates must be accompanied by text or a picture.

Related articles

Medical emergencies can happen anytime, anywhere — at school or work or while traveling. Dependin...

3 Benefits of MS Medical Alert Bracelets

Medical emergencies can happen anytime, anywhere — at school or work or while traveling. Dependin...
Menopause can cause many uncomfortable symptoms. People with multiple sclerosis (MS) may wonder a...

MS and Menopause: 7 Things You Should Know

Menopause can cause many uncomfortable symptoms. People with multiple sclerosis (MS) may wonder a...
If multiple sclerosis (MS) symptoms are making it difficult for you to keep up with the demands o...

When To Quit Working With MS vs. Taking a Medical Leave

If multiple sclerosis (MS) symptoms are making it difficult for you to keep up with the demands o...
Multiple sclerosis (MS) advocate Brittany Quiroz writes online as “A Hot MS” to forge connection...

Tips for Keeping Your Cognition Sharp

Multiple sclerosis (MS) advocate Brittany Quiroz writes online as “A Hot MS” to forge connection...
Lea este artículo en españolWe all respond differently to information about our health. After lea...

Just Diagnosed With MS — Now What? 9 First Steps

Lea este artículo en españolWe all respond differently to information about our health. After lea...
Maintaining independence is a concern for many people with multiple sclerosis (MS). And everyone ...

6 Resources for Independent Living and Managing MS

Maintaining independence is a concern for many people with multiple sclerosis (MS). And everyone ...

Recent articles

Peppermint and chili peppers add flavor to your favorite foods, but did you know that they’re als...

Topical Treatments To Relieve MS Pain: What Works?

Peppermint and chili peppers add flavor to your favorite foods, but did you know that they’re als...
Multiple sclerosis (MS) and stiff-person syndrome (SPS) are both autoimmune diseases affecting th...

Is It MS or Stiff Person Syndrome? 9 Ways To Tell the Difference

Multiple sclerosis (MS) and stiff-person syndrome (SPS) are both autoimmune diseases affecting th...
With age comes wisdom, and if you’re lucky, it may also come with fewer multiple sclerosis (MS) r...

Is It Safe for Older People With MS To Stop Taking a DMT?

With age comes wisdom, and if you’re lucky, it may also come with fewer multiple sclerosis (MS) r...
When it comes to multiple sclerosis (MS), having the right doctors on your side is essential. Wit...

8 Doctors Who Treat MS: Which Specialist Handles Which Problem?

When it comes to multiple sclerosis (MS), having the right doctors on your side is essential. Wit...
You look in the mirror, and something’s different. One side of your face is drooping. The muscles...

Bell’s Palsy and MS: What’s the Connection?

You look in the mirror, and something’s different. One side of your face is drooping. The muscles...
If you’re living with multiple sclerosis (MS) and are experiencing new or worsening symptoms, you...

Is It Stroke or MS Symptoms? 5 Ways To Tell the Difference

If you’re living with multiple sclerosis (MS) and are experiencing new or worsening symptoms, you...
MyMSTeam My multiple sclerosis Team

Thank you for subscribing!

Become a member to get even more:

sign up for free

close